Shahrukh Khan receives top French honour

Published
14

MUMBAI: Bollywood superstar Shahrukh Khan was on Tuesday bestowed with France's highest civilian award for his contribution to cinema.

The actor was honoured as a “Knight of the Legion of Honour” by French foreign minister Laurent Fabius at the Taj Mahal Palace hotel in India's entertainment capital Mumbai.

“There are different moments in life that make you feel that you are on the right track. This is one such moment,” said Khan, 48, one of Indian cinema's most recognisable faces.

Fabius said the French people hailed the actor's “talent and generosity, which arouse the enthusiasm of a vast audience across the world, transcending cultural and historical differences and bringing together people from all walks of life to his films”.

In a career spanning three decades, Khan has made himself the biggest box office draw in Bollywood as the hero of romantic dramas and high-octane action movies.

Fellow Indian superstar Amitabh Bachchan received the French award in 2007.

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...